RAPT Therapeutics Reports Second Quarter 2020 Financial Results Portfolio News / Karina Tin August 13, 2020 RAPT Therapeutics Reports Second Quarter 2020 Financial Results Read More »
NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results Portfolio News / Karina Tin August 12, 2020 NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results Read More »
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress Portfolio News / Karina Tin August 10, 2020 Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress Read More »
Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates Portfolio News / Karina Tin August 6, 2020 Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates Read More »
Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update Portfolio News / Karina Tin August 5, 2020 Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update Read More »
ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update Portfolio News / Karina Tin August 5, 2020 ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update Read More »
Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing Portfolio News / Karina Tin July 29, 2020 Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing Read More »
NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Portfolio News / Karina Tin July 27, 2020 NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Read More »
Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering Portfolio News / Karina Tin July 23, 2020 Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering Read More »
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Portfolio News / Karina Tin July 20, 2020 Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Read More »